Skip to content
Clinical Trials
Our Network
Our Story
Clinical Trials
Our Network
Our Story
OnCore Login
Clinical Trials
Current Trials
Publications
Our Network
Clinical Trial Working Groups
Sponsor-Investigators
Fostering an Environment of Mentorship
Member Sites
Partners in Research
About
Our Story
Our Team
Annual Reports
Services
Biorepository & Correlative Services
Rapid Accrual
Efficient Timelines for Activation
Regulatory Compliance
Accurate & Relevant Data
News & Events
HCRN Calendar
Oncology Meetings
Make a Difference
Donate Now
Fundraising Events
Advocacy Organizations
Honor Your Hero
Careers
Contact
OnCore Login
network member
University of Cincinnati Cancer Center
Cincinnati, Ohio
About Network Member
Website
:
https://www.uchealth.com/en/cancer-center
https://www.uchealth.com/en/cancer-center
Currently Enrolling
HCRN-GU20-436
NePtune: A Phase 2 Study of Neoadjuvant PARP Inhibition followed by Radical Prostatectomy in Patients with Unfavorable Intermediate-Risk or High-Risk Prostate Cancer with BRCA1/2 Gene Alterations
Cancer areas:
Prostate
Columbia University Irving Medical Center
Memorial Sloan Kettering Cancer Center
Moores Cancer Center at UC San Diego Health
Penn Medicine Abramson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Cincinnati Cancer Center
Learn More
See clinicaltrials.gov
Current Trials
Our Network
Our Story
X